NEW YORK (AP) — During a court hearing, Luigi Mangione spoke out against the dual prosecution in his murder case of UnitedHealthcare CEO Brian Thompson, stating, It’s the same trial twice. One plus one is two. Double jeopardy by any commonsense definition.
The judge has set the state trial to begin on June 8, 2023, just three months before the scheduled jury selection for his federal case, which outlines accusations of stalking leading up to the murder.
Judge Gregory Carro, after discussions with both prosecutors and defense attorneys, indicated that the start of the state trial could be moved to September 8 if the appeal surrounding the federal proceedings is delayed.
Mangione’s legal team expressed concerns that the June trial date is impractical as they will be heavily involved in preparing for the federal charges at that time. Defense lawyer Karen Friedman Agnifilo stated, Mr. Mangione is being put in an untenable situation, referring to the conflict between the two prosecution offices.
As tensions persisted over the scheduling, Prosecutor Joel Seidemann argued for an earlier state trial to avoid potential prejudice against the state’s interests. He noted that Thompson's family is eager for the state case to proceed.
It's crucial to navigate these proceedings carefully, as a federal trial before the state trial could hinder further prosecutions due to double jeopardy protections under New York law.
Mangione, 27, maintains his not-guilty plea in state and federal cases, both of which could result in life sentences if convicted. Recent rulings have limited prosecutors from seeking the death penalty against him.
The complex timeline has been challenging for both sides, particularly given the serious nature of the accusations, which include evidence collected from a 9 mm handgun linked to the murder.
Ultimately, Mangione will not return to court until May, when pivotal rulings on evidence admissibility in the state trial are expected. The dual nature of his trials continues to draw significant legal and public scrutiny, making the upcoming proceedings critical milestones in this high-profile case.




















